Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination

被引:36
作者
Bridle, Byram W. [1 ]
Nguyen, Andrew [2 ]
Salem, Omar [2 ]
Zhang, Liang [2 ]
Koshy, Sandeep [2 ]
Clouthier, Derek [2 ]
Chen, Lan [2 ]
Pol, Jonathan [2 ]
Swift, Stephanie L. [2 ]
Bowdish, Dawn M. E. [2 ]
Lichty, Brian D. [2 ]
Bramson, Jonathan L. [2 ]
Wan, Yonghong [2 ]
机构
[1] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada
[2] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
基金
加拿大健康研究院;
关键词
DENDRITIC CELLS; MARGINAL ZONE; MARABA VIRUS; LYMPH-NODES; EFFECTOR; ACTIVATION; EXPRESSION; NAIVE; LOCALIZATION; GENERATION;
D O I
10.4049/jimmunol.1600106
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Effector T cells (T-EFF) are a barrier to booster vaccination because they can rapidly kill Ag-bearing APCs before memory T cells are engaged. We report in this study that i.v. delivery of rhabdoviral vectors leads to direct infection of follicular B cells in the spleen, where the earliest evidence of secondary T cell responses was observed. This allows booster immunizations to rapidly expand CD8(+) central memory T cells (T-CM) during the acute phase of the primary response that is dominated by TEFF. Interestingly, although the ablation of B cells before boosting with rhabdoviral vectors diminishes the expansion of memory T cells, B cells do not present Ags directly. Instead, depletion of CD11c(+) dendritic cells abrogates secondary T cell expansion, suggesting that virus-infected follicular B cells may function as an Ag source for local DCs to subsequently capture and present the Ag. Because TCM are located within B cell follicles in the spleen whereas TEFF cannot traffic through follicular regions, Ag production and presentation by follicular APCs represent a unique mechanism to secure engagement of TCM during an ongoing effector response. Our data offer insights into novel strategies for rapid expansion of CD8(+) T cells using prime-boost vaccines by targeting privileged sites for Ag presentation.
引用
收藏
页码:4587 / 4595
页数:9
相关论文
共 44 条
[1]   Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming [J].
Allan, Rhys S. ;
Waithman, Jason ;
Bedoui, Sammy ;
Jones, Claerwen M. ;
Villadangos, Jose A. ;
Zhan, Yifan ;
Lew, Andrew M. ;
Shortman, Ken ;
Heath, William R. ;
Carbone, Francis R. .
IMMUNITY, 2006, 25 (01) :153-162
[2]   Migratory and Lymphoid-Resident Dendritic Cells Cooperate to Efficiently Prime Naive CD4 T cells [J].
Allenspach, Eric J. ;
Lemos, Maria P. ;
Porrett, Paige M. ;
Turka, Laurence A. ;
Laufer, Terri M. .
IMMUNITY, 2008, 29 (05) :795-806
[3]   CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells [J].
Bassett, Jennifer D. ;
Yang, Teng Chih ;
Bernard, Dannie ;
Millar, James B. ;
Swift, Stephanie L. ;
McGray, A. J. Robert ;
VanSeggelen, Heather ;
Boudreau, Jeanette E. ;
Finn, Jonathan D. ;
Parsons, Robin ;
Evelegh, Carole ;
Damjanovic, Daniela ;
Grinshtein, Natalie ;
Divangahi, Maziar ;
Zhang, Liang ;
Xing, Zhou ;
Wan, Yonghong ;
Bramson, Jonathan L. .
BLOOD, 2011, 117 (04) :1146-1155
[4]   Bone marrow-derived cells expand memory CD8+ T cells in response to viral infections of the lung and skin [J].
Belz, GT ;
Wilson, NS ;
Smith, CM ;
Mount, AM ;
Carbone, FR ;
Heath, WR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (02) :327-335
[5]   IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells [J].
Boudreau, Jeanette E. ;
Stephenson, Kyle B. ;
Wang, Fuan ;
Ashkar, Ali A. ;
Mossman, Karen L. ;
Lenz, Laurel L. ;
Rosenthal, Kenneth L. ;
Bramson, Jonathan L. ;
Lichty, Brian D. ;
Wan, Yonghong .
CANCER RESEARCH, 2011, 71 (07) :2497-2506
[6]   Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines [J].
Bridle, Byram W. ;
Clouthier, Derek ;
Zhang, Liang ;
Pol, Jonathan ;
Chen, Lan ;
Lichty, Brian D. ;
Bramson, Jonathan L. ;
Wan, Yonghong .
ONCOIMMUNOLOGY, 2013, 2 (08)
[7]   Potentiating Cancer Immunotherapy Using an Oncolytic Virus [J].
Bridle, Byram W. ;
Stephenson, Kyle B. ;
Boudreau, Jeanette E. ;
Koshy, Sandeep ;
Kazdhan, Natasha ;
Pullenayegum, Eleanor ;
Brunelliere, Jerome ;
Bramson, Jonathan L. ;
Lichty, Brian D. ;
Wan, Yonghong .
MOLECULAR THERAPY, 2010, 18 (08) :1430-1439
[8]   Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus [J].
Bridle, Byram W. ;
Boudreau, Jeanette E. ;
Lichty, Brian D. ;
Brunelliere, Jerome ;
Stephenson, Kyle ;
Koshy, Sandeep ;
Bramson, Jonathan L. ;
Wan, Yonghong .
MOLECULAR THERAPY, 2009, 17 (10) :1814-1821
[9]   Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus [J].
Brun, Jan ;
McManus, Dan ;
Lefebvre, Charles ;
Hu, Kang ;
Falls, Theresa ;
Atkins, Harold ;
Bell, John C. ;
McCart, J. Andrea ;
Mahoney, Douglas ;
Stojdl, David F. .
MOLECULAR THERAPY, 2010, 18 (08) :1440-1449
[10]  
BYRNE JA, 1988, J IMMUNOL, V141, P3249